Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction

Commonly used drugs for treating many conditions are either natural products or derivatives. In silico modelling has identified several natural products including quercetin as potential highly effective disruptors of the initial infection process involving binding to the interface between the SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Williamson, Gary, Kerimi, Asimina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316054/
https://www.ncbi.nlm.nih.gov/pubmed/32593613
http://dx.doi.org/10.1016/j.bcp.2020.114123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316054/
https://www.ncbi.nlm.nih.gov/pubmed/32593613
http://dx.doi.org/10.1016/j.bcp.2020.114123

Ejemplares similares